BioSante Pharmaceuticals, Inc. (Nasdaq: BPAX) today announced that it has received commitments from several institutional investors to purchase $15 million ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE